药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Fosamprenavir
Choline magnesium trisalicylate
The therapeutic efficacy of Riociguat can be decreased when used in combination with Choline magnesium trisalicylate.
Fosamprenavir
Salsalate
The therapeutic efficacy of Riociguat can be decreased when used in combination with Salsalate.
Fosamprenavir
Magnesium salicylate
The therapeutic efficacy of Riociguat can be decreased when used in combination with Magnesium salicylate.
Fosamprenavir
Mometasone furoate
The metabolism of Riociguat can be decreased when combined with Mometasone furoate.
Fosamprenavir
Fluticasone
The metabolism of Riociguat can be decreased when combined with Fluticasone.
Fosamprenavir
Trametinib
The metabolism of Riociguat can be decreased when combined with Trametinib.
Fosamprenavir
Lenvatinib
The metabolism of Riociguat can be decreased when combined with Lenvatinib.
Fosamprenavir
Cilnidipine
The risk or severity of adverse effects can be increased when Cilnidipine is combined with Riociguat.
Fosamprenavir
Clevidipine
The risk or severity of adverse effects can be increased when Clevidipine is combined with Riociguat.
Fosamprenavir
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Riociguat.
Fosamprenavir
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Riociguat.
Fosamprenavir
Fimasartan
The risk or severity of adverse effects can be increased when Fimasartan is combined with Riociguat.
Fosamprenavir
Arotinolol
The risk or severity of adverse effects can be increased when Arotinolol is combined with Riociguat.
Fosamprenavir
Nitrous acid
The risk or severity of adverse effects can be increased when Nitrous acid is combined with Riociguat.
Fosamprenavir
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Riociguat.
Fosamprenavir
Empagliflozin
The risk or severity of adverse effects can be increased when Empagliflozin is combined with Riociguat.
Fosamprenavir
Azilsartan medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Riociguat.
Fosamprenavir
Nesiritide
The risk or severity of adverse effects can be increased when Nesiritide is combined with Riociguat.
Fosamprenavir
Barbexaclone
Barbexaclone may increase the hypotensive activities of Riociguat.
Fosamprenavir
Barbital
Barbital may increase the hypotensive activities of Riociguat.